Immunovant Inc Earnings

Immunovant Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, Immunovant Inc has generated NaN% jump in its revenue since last 3-months.

Immunovant Inc’s net profit jumped 0.44% since last year same period to $-110.64Mn in the Q4 2025. On a quarterly growth basis, Immunovant Inc has generated 12.54% jump in its net profits since last 3-months.

Immunovant Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2025. On a quarterly growth basis, Immunovant Inc has generated NaN% jump in its net profit margins since last 3-months.

Immunovant Inc’s earning per share (EPS) estimates for the current quarter stand at -0.73 - a -2.38% fall from last quarter’s estimates.

Immunovant Inc’s earning per share (EPS) estimates for the current year stand at -0.73.

Immunovant Inc’s earning per share (EPS) jumped 29.3% since last year same period to -0.54 in the Q4 2025. This indicates that the Immunovant Inc has generated 29.3% annual rate of jump in its earning per share (EPS) in the last 4 quarters.